Clinicopathological significance of sialyl Lex expression in human gallbladder carcinoma

Oncology Reports

Volumn 11, Issue 6, 2004, Pages 1139-1143

  Kashiwagi, Hiroyuki ^a   Kijima, Hiroshi ^a   Dowaki, Shoichi ^a   Ohtani, Yasuo ^a   Tobita, Kosuke ^a   Yamazaki, Hitoshi ^a   Nakamura, Masato ^a   Ueyama, Yoshito ^a   Tanaka, Makiko ^a   Inokuchi, Sadaki ^a   Imaizumi, Toshihide ^a   Makuuchi, Hiroyasu ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenocarcinoma; FH6; Gallbladder; Lymphatic invasion

Indexed keywords

5 ACETYLNEURAMINYL (2 3) GALACTOSYL (1 4) (FUCOPYRANOSYL (1 3)) N ACETYLGLUCOSAMINE; 5-ACETYLNEURAMINYL-(2-3)-GALACTOSYL-(1-4)-(FUCOPYRANOSYL-(1-3))-N-ACETYLGLUCOSAMINE; CD15 ANTIGEN; OLIGOSACCHARIDE; TUMOR MARKER;

ADENOCARCINOMA; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; ENZYME IMMUNOASSAY; FEMALE; GALLBLADDER TUMOR; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; STROMA CELL; SURVIVAL RATE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTIGENS, CD15; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OLIGOSACCHARIDES; STROMAL CELLS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 16544375413     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.6.1139     Document Type: Article

References (29)

1. Saul SH: Gallbladder and extrahepatic biliary tree. In: Diagnostic Surgical Pathology. Sternberg SS (ed). Raven Press, New York, pp1581-1612, 1994.
2. Albores-Saavedra J and Henson DE: Tumor of the gallbladder and extrahepatic bile ducts. Atlas of tumor pathology. 2nd series. Fascicle 22. Armed Forces Institute of Pathology, Washington, DC, pp28-111, 1988.
3. Donohue JH, Stewart AK and Menck HR: The national cancer data base report on carcinoma of the gallbladder, 1989-1995. Cancer 83: 2618-2628, 1998. (Pubitemid 29019584)
4. Tsukada K, Kurosaki I, Uchida K, Shirai Y, Oohashi Y, Yokoyama N, Watanabe H and Hatakeyama K: Lymph node spread from carcinoma of the gallbladder. Cancer 80: 661-667, 1997. (Pubitemid 27339820)
5. Tsukada K, Hatakeyama K, Kurosaki I, Uchida K, Shirai Y, Muto T and Yoshida K: Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery 120: 816-822, 1996. (Pubitemid 26378182)
6. Kijima H, Watanabe H, Iwafuchi M and Ishihara N: Histogenesis of gallbladder carcinoma from investigation of early carcinoma and microcarcinoma. Acta Pathol Jpn 39: 235-244, 1989. (Pubitemid 19156649)
7. Ohtani Y, Kijima H, Dowaki S, Kashiwagi H, Tobita K, Tsukui M, Tanaka Y, Tsuchida T, Tokunaga T, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Tajima T and Makuuchi H: Stromal expression of thrombospondin-1 (TSP1) is correlated with growth and metastasis of human gallbladder carcinoma. Int J Oncol 15: 453-457, 1999.
8. Dowaki S, Kijima H, Ohtani Y, Kashiwagi H, Tobita K, Tsukui M, Tanaka Y, Tsuchida T, Tokunaga T, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Tajima T and Makuuchi H: CEA immunohistochemical localization is correlated with growth and metastasis of human gallbladder carcinoma. Int J Oncol 16: 49-53, 2000.
9. Kashiwagi H, Kijima H, Dowaki S, Ohtani Y, Tobita K, Tsukui M, Tanaka Y, Matsubayashi H, Tsuchida T, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Tajima T and Makuuchi H: DF3 expression in human gallbladder carcinoma: its significance for lymphatic invasion. Int J Oncol 16: 455-459, 2000.
10. a expression is correlated with vascular invasion of human gallbladder adenocarcinoma. Int J Oncol 17: 55-60, 2000.
11. Kashiwagi H, Kijima H, Dowaki S, Ohtani Y, Tobita K, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Inokuchi S and Makuuchi H: MUC1 and MUC2 expression in human gallbladder carcinoma: A clinicopathological study and relationship with prognosis. Oncol Rep 8: 485-489, 2001. (Pubitemid 33758441)
12. Tobita K, Kijima H, Chino O, Dowaki S, Kashiwagi H, Tanaka M, Ohtani Y, Inokuchi S and Makuuchi H: Pancreatic acinar cell carcinoma with endocrine differentiation: Immunohistochemical and ultrastructural analyses. Anticancer Res 21: 2131-2134, 2001. (Pubitemid 32728879)
13. 6). J Biol Chem 259: 10511-10517, 1984.
14. x expression in gastric carcinoma correlates with venous invasion and poor outcome. Gastroenterology 114: 462-470, 1998.
15. x expression difines invasive and metastatic properties of bladder carcinoma. Cancer 94: 673-685, 2002.
16. x antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res 53: 3632-3637, 1993.
17. Sobin LH and Wittekind C (eds): Gallbladder. In: TNM Classification of Malignant Tumours. 4th edition. Wiley-Liss, Inc., New York, pp78-80, 1997.
18. Avraneas S and Ternynck T: Peroxidase labeled antibody and Fab conjugates with enhanced intracellular penetration. Immunochemistry 8: 1175-1179, 1971.
19. Tanaka H, Kijima H, Tokunaga T, Tajima T, Himeno S, Kenmochi T, Oshiba G, Kise Y, Nishi T, Chino O, Shimada H, Machimura T, Tanaka M and Makuuchi H: Frequent expression of inducible nitric oxide synthase in esophageal squamous cell carcinomas. Int J Oncol 14: 1069-1073, 1999.
20. Takada A, Ohmori K, Yoneda T, Tsuyuoka K, Hasegawa A, Kiso M and Kannagi R: Contribution of carbohydrate antigen sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res 53: 354-361, 1993. (Pubitemid 23031849)
21. Takada A, Ohmori K, Takahashi N, Tsuyuoka K, Yago A, Zenika K, Hasegawa A and Kannagi R: Adhesion of cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. Biochem Biophys Res Commun 179: 713-719, 1991.
22. Tyrrel D, James P, Rao N, Foxall C, Abbas S, Dasgupta F, Nashed M, Hasegawa A, Kiso M, Asa D, Kidd J and Brandley BK: Structural requirements for the carbohydrate ligand of E-selectin. Proc Natl Acad Sci USA 88: 10372-10376, 1991. (Pubitemid 21915837)
23. Berg EL, Robinson MK, Mansson O, Butcher EC and Magnani JL: A carbohydrate domain common to both sialyl Le(a) and sialyl Le(x) is recognized by the endothelial cell leukocyte adhesion molecule ELAM-1. J Biol Chem 226: 14869-14872, 1991. (Pubitemid 21907587)
24. Berg EL, Magnani JL, Warnock RA, Robinson MK and Butcher EC: Comparison of L-selectin and E-selectin ligand specificities: the L-selectin can bind the E-selectin ligands sialyl Le(x) and sialyl Le(a). Biochem Biophys Res Commun 184: 1048-1055, 1992.
25. Klopocki AG, Laskowska A, Antoniewicz-Papis J, Duk M, Lisowska E and Ugorski M: Role of sialosyl Lewis (a) in adhesion of colon cancer cells-the antisense RNA approach. Eur J Biochem 253: 309-318, 1998. (Pubitemid 28182334)
26. Hoff SD, Irimura T, Matsushita Y, Ota DM, Cleary KR and Hakomori S: Metastatic potential of colon carcinoma: expression of ABO/Lewis-related antigens. Arch Surg 125: 206-209, 1990. (Pubitemid 20060645)
27. x antigen in liver metastasis of human colorectal carcinoma. Cancer Res 49: 6883-6888, 1989.
28. Lee YC, Yang MH, Huang MH, Lai SL and Perng RP: Serum sialyl stage-specific embryonic antigen levels in adenocarcinoma of lung. J Forman Med Assoc 91: 760-763, 1992.
29. Hanisch FG, Hanski C and Hasegawa A: Sialyl LewisX antigen as defined by monoclonal antibody AM-3 is a marker of dysplasia in the colonic adenoma-carcinoma sequence. Cancer Res 52: 3138-3144, 1992.